Introduction
The condition of critically ill patients is likely to deteriorate if they are moved, whether between hospitals or within the same hospital.1 Such patients may benefit ultimately from being moved either from a general ward or a peripheral hospital to an adequately equipped and staffed intensive therapy unit or from an intensive therapy unit to a specialist investigative unit-for instance, for computed tomography or ultrasound scanning. Many clinicians, however, are concerned about the risks of the journey itself. Either they may refuse to move the patient and thus deny him specialist investigation or treatment or they may disconnect the patient temporarily from cardiovascular monitoring apparatus and from controlled respiratory and cardiovascular support and rush him to his destination to minimise the time "at risk."
To overcome this problem a mobile intensive care unit incorporating complete, independently powered intensive care facilities was developed in Glasgow [2] [3] [4] and was shown to provide a means of moving critically ill patients safely, either between or within hospitals.5 As a custom-modified ambulance was purchased,* however, the Glasgow mobile intensive care probes enable gas supplies to be obtained from pipeline systems in the ward or theatre before moving the patient or in the ambulance during the journey. An injector suction device (Medishield) is fitted. All gas and suction controls are protected by a crash bar. The gas is normally conducted to the ventilator, mounted on a shelf beneath the patient. A Manley Pulmovent MPP (Medishield) ventilator was selected because, being a gas-driven minute volume divider, it is economic in its use of gases, requires no electrical power source, and has no external moving parts. Positive end-expiratory pressure can be applied easily, and double-length inspiratory and expiratory tubing is fitted so that the ventilator can be used while the patient is being stabilised in his hospital bed before the journey.
A cardiovascular monitor (Statscope II; Becton-Dickinson) is mounted above the patient's feet. The oscilloscope displays electrocardiograph and intra-arterial pressure or finger plethysmograph traces, with a digital display of heart rate; systolic, mean, and diastolic arterial pressures; and temperature. The The trolley is loaded and unloaded with the help of aluminium ramps (fig 3) . These are stored during transit on the floor beneath the trolley but are attached easily to the rear of the floor when required.
Six storage cupboards at the rear of the vehicle carry a wide range of disposable and non-disposable items of equipment that might be required during the journey.
Staffing
Requests to use the mobile intensive care unit are first made to the nursing staff in the intensive therapy unit. The An acceleration force towards the head of a seriously ill patient tends to cause fewer pronounced cardiovascular problems than an acceleration force towards the feet.6 In British ambulances, which are relatively underpowered, acceleration forces tend to be less severe than deceleration forces produced by braking, and critically ill patients travel more safely head first. Patients with raised intracranial pressure, however, may suffer further increases in pressure in response to an acceleration force towards the head. We have yet to determine whether in practice such patients will benefit more from travelling feet first.
Vibrations during travel can cause cardiovascular complications,6
I but in the design of a patient-suspension system for a unit such as this a compromise must be found between absorp-tion of vibrations and some rigidity to support the vertebral column should external cardiac compression be necessary. A soft spring mattress (or springs in the trolley axles) makes efficient closed chest cardiac massage difficult. An air mattress effectively prevents transmission of vibration from the trolley to the patient and damps inertial movement. If cardiac massage is necessary the mattress can be deflated within 10 seconds.
Although a hydraulic loading lift on the tail of the ambulance would allow the trolley to be maintained in a horizontal position, such devices are very expensive to fit, and we thought that tilting patients for the few seconds needed to load or unload the trolley would be unlikely to cause anything more than a transient alteration in cardiovascular function.
Using surplus or renovated items of equipment where possible has minimised the capital cost of the mobile intensive care unit. The ventilator, defibrillator, and monitor were purchased specifically for the mobile intensive care unit, as were some parts of the gas-supply system. Engineers in the Nuffield department of anaesthetics modified the trolley, and the ambulance service undertook the alterations and refurbishing of the ambulance. The trolley and its equipment are maintained by technicians of the Nuffield department of anaesthetics, and the ambulance by ambulance service engineers.
As the mobile intensive care unit is manned by those members of the ambulance, medical, and nursing staff who are on call running costs should be low. A senior member of intensive therapy unit medical staff is readily available at all times, and can usually leave the unit temporarily to undertake a transfer. On rare occasions when this is not possible a senior member of the on-call anaesthetic team accompanies the mobile unit. An ambulance crew is required to move the patient whether the mobile intensive care unit is used or not, though the total period of the journey may be longer when it is used. If there is to be a considerable delay before the patient is fit to travel the ambulance crew can resume their normal duties and be called back when required.
We believe that a mobile intensive care unit can make an important contribution towards the safe movement of critically ill patients and that it is a logical extension of a regional intensive care service. With co-operation between clinical, technical, and ambulance staff, such units can be brought into service with low construction and running costs.
Antihypertensive treatment combined with a beta-sympathomimetic drug given to delay premature labour may cause congestive cardiac failure.
tained below 100 mm Hg with alpha-methyldopa, the daily requirement increasing from 1 5 to 2-5 g. Premature labour began at 32 weeks' gestation, and her blood pressure rose to 210/140 mm Hg. Salbutamol, 6 ,ug/min, was infused to suppress uterine activity. Hydrallazine was started with a 10-mg bolus and an infusion was maintained at 27 ,ug/min for three hours. Six hours after starting salbutamol the patient became breathless with tachypnoea (30 respirations/min). Central venous pressure rose to 8 cm H,2O, and a third heart sound was heard. An electrocardiogram (ECG) showed sinus tachycardia of 130 beats/min.
The patient became anuric: the plasma concentration of potassium was 3-2 mmol/l (mEq/l) (normal range 3 7-5 0 mmol/l) and of bicarbonate 11 mmol/l (mEq/l) (normal range 24-34 mmol/l). The tachypnoea, central venous pressure, and plasma bio-
